Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The proteasome--an emerging therapeutic target in cancer.

× No keyword cloud information.

26 in total

Review 1. Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors: Trine H Mogensen
Journal: Clin Microbiol Rev Date: 2009-04 Impact factor: 26.132

2. Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IkappaBalpha.

Authors: Hai-Yen Vu; Ashish Juvekar; Chandra Ghosh; Sitharam Ramaswami; Dung Hong Le; Ivana Vancurova
Journal: Arch Biochem Biophys Date: 2008-04-29 Impact factor: 4.013

Review 3. Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors: Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal: Support Care Cancer Date: 2006-07-04 Impact factor: 3.603

Review 4. Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors: C N Belcher; N Vij
Journal: Curr Mol Med Date: 2010-02 Impact factor: 2.222

5. Analysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF.

Authors: Cristina Zanini; Giorgia Mandili; Daniele Bertin; Francesco Cerutti; Denisa Baci; Marco Leone; Isabella Morra; Luca di Montezemolo Cordero; Marco Forni
Journal: Childs Nerv Syst Date: 2011-06-30 Impact factor: 1.475

Review 6. Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking.

Authors: Verónica Alonso; Peter A Friedman
Journal: Mol Endocrinol Date: 2013-03-07

7. The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery.

Authors: Biyin Cao; Xinliang Mao
Journal: Am J Blood Res Date: 2011-05-25

8. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.

Authors: P P Scaglioni; T M Yung; S Choi; S C Choi; C Baldini; G Konstantinidou; P P Pandolfi
Journal: Mol Cell Biochem Date: 2008-06-20 Impact factor: 3.396

Review 9. [Designer-drugs in tumor treatment].

Authors: C Beck; M Kneba
Journal: Internist (Berl) Date: 2004-06 Impact factor: 0.743

10. Caspase-3 activation as a key factor for HBx-transformed cell death.

Authors: A Kim; O S Kwon; S O Kim; L He; E Y Bae; M S Lee; S J Jeong; J H Shim; D Y Yoon; C H Kim; A Moon; K E Kim; J S Ahn; B Y Kim
Journal: Cell Prolif Date: 2008-10 Impact factor: 6.831